Fast Vote Count Surprises and Delights Argentina
28.10.2019 21:42:00 EET | Business Wire | Press release
Argentina processed election results with record-breaking speed during its general elections thanks to the new system implemented in partnership with technology company Smartmatic. The vote was held on October 27.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191028005666/en/
Telegram processing rates on election night, 2015 vs. 2019. (Photo: Business Wire)
Only three hours after voting ended, 70.48% of the tallying reports (called “telegrams” in Argentina) had been digitized, securely transmitted and uploaded into the system. By midnight, 96.08% of telegrams were processed.
Election observers representing the political parties closely monitored the entire process. The high level of transparency and speed with which the results were processed and published allowed the main candidates to publicly accept the outcomes shortly after results were announced.
“We are honored to have supported Argentine authorities for this important election by deploying Smartmatic’s unmatched technology. We were able to facilitate fast, accurate results that gave peace of mind to political parties and the country in general,” said Antonio Mugica, CEO of Smartmatic.
According to information released by election authorities, voter participation exceeded 80%. Voters chose among four candidates for head of government and six formulas for president and vice president. In eight provinces, 72 candidates vied for senate seats and 595 candidates competed to become deputies at the national level.
Smartmatic provided secure technology both for the digitation and transmission of telegrams, and for the consolidation and publication of results. Just as in the primaries held in August, telegrams were transmitted directly from over 10,000 voting centers to two consolidation centers. Approximately 1,700 operators at the consolidation centers transcribed and loaded into the system the information contained in the telegrams.
"Because of the speed and accuracy with which results were published, misinformation about the technology that had been widely distributed across social media and other news outlets fell flat and was easily discredited. Argentines today welcomed the innovations introduced by the authorities that make elections more efficient and more transparent," added Mugica.
Smartmatic participated in Argentina’s 2019 election cycle after winning two public bids in which international election technology companies competed.
It is anticipated that, as in the primaries, the provisional results will be an accurate reflection of the final vote count. In August, the difference between the provisional and final results was less than 1% in each of the Argentine provinces.
About Smartmatic
Smartmatic specializes in the design and deployment of election system technologies. As the global leader in providing secure, transparent, verifiable voting systems, Smartmatic is setting the standard for election integrity worldwide including encrypted results transmission, paper ballot back-up, extensive auditing and the first use of blockchain technology to secure online voting. Additional information about Smartmatic can be found at: www.smartmatic.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191028005666/en/
Contact information
Smartmatic
Mrs. Samira Saba, +1-561-862-0747
Marketing and Communications Director
Communications@smartmatic.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 10:10:00 EEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging
TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 10:00:00 EEST | Press release
Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803353435/en/ Adtran’s SDX 6400 Series is helping TOHKnet demonstrate how Japan’s operators can migrate to 50G PON without disrupting existing PON services. “As demand for digital services continues to grow, this trial is a key milestone for the future of fiber access in Jap
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 10:00:00 EEST | Press release
The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the project continues to captivate audiences through its
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer4.8.2026 10:00:00 EEST | Press release
Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-mutated advanced / metastatic breast cancer. Rupitasertib, is a first-in-class oral dual-node PI3K/AKT/mTOR (PAM) pathway inhibitor, which selectively inhibits S6K and AKT1/3. Rupitasertib was purposefully and rationally designed to target S6K for potent PAM inhibition and AKT1/3 to block the AKT compensatory feedback loop, while sparing AKT2 to avoid hyperglycemia, which we believe will lead to a superior efficacy and safety profile compared to other PAM pathway inhibitors. Under the terms of the agreement, Roche will s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
